Celldex Therapeutics shares owned by Monarch Partners Asset Management
Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by Monarch Partners Asset Management
from 13F filings
Historical chart of Monarch Partners Asset Management investment in Celldex Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Celldex Therapeutics held by Monarch Partners Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Celldex Therapeutics by Monarch Partners Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2022-12-31 | $2.0M | 46k | 44.57 |
More positions owned by Monarch Partners Asset Management
View all positions for Monarch Partners Asset Management